Psoriasis vs. Eczema: How to Tell the Difference

You've been told your skin condition is "just eczema" or "probably psoriasis," but the rash keeps coming back, the treatments aren't working, and no one has explained why your skin looks different from the pictures online. Both conditions cause red, inflamed, itchy skin, but they start from completely different biological processes. One is an autoimmune condition driven by your immune system attacking your own skin cells. The other is a barrier defect that lets the outside world in.

Key Takeaways

• Psoriasis is an autoimmune condition where the immune system accelerates skin cell turnover.
• Eczema involves a defective skin barrier that allows irritants and allergens to penetrate.
• Psoriasis creates thick, raised, silvery plaques while eczema causes dry, weeping, or crusty patches.
• Psoriasis typically affects elbows, knees, and scalp while eczema favors skin folds and flexures.
• Psoriasis flares are driven by immune activation while eczema flares from barrier breakdown.
• Systemic inflammation in psoriasis raises cardiovascular risk beyond the skin.
• Treatment approaches differ: psoriasis often requires immune-targeted therapy while eczema focuses on barrier repair.

What Psoriasis and Eczema Actually Are at the Cellular Level

Psoriasis is an autoimmune disease. Your immune system, specifically a subset of T cells called Th17 cells, becomes activated and releases inflammatory cytokines including IL-17, IL-22, and TNF-alpha. These signals tell your skin cells to multiply at a dramatically accelerated rate. Normal skin cell turnover takes about 28 days. In psoriasis, that cycle compresses to 3 to 5 days. The result is a pileup of immature skin cells on the surface, forming the thick, scaly plaques characteristic of the condition. The inflammation is not just local. It's systemic, which is why psoriasis is associated with increased risk of psoriatic arthritis, cardiovascular disease, and metabolic syndrome.

Eczema (or atopic dermatitis) is fundamentally a barrier problem. The outermost layer of your skin, the stratum corneum, is supposed to function like a brick wall, with skin cells as bricks and lipids as mortar. In eczema, that wall is compromised. Many people with eczema carry mutations in the filaggrin gene, which codes for a structural protein essential to barrier integrity. Without adequate filaggrin, the skin loses water, becomes dry and cracked, and allows allergens, irritants, and pathogens to penetrate. This triggers an immune response, but it's reactive, not primary. The immune system is responding to what's getting through the broken barrier, not attacking the skin itself. Eczema is part of the atopic march, a progression that often includes food allergies, asthma, and allergic rhinitis, all driven by an overactive Th2 immune response.

How Psoriasis and Eczema Look Different on the Skin

Psoriasis plaques are raised, well-demarcated, and covered with silvery-white scales. The scales are thick and adherent. If you scrape them off, you may see pinpoint bleeding underneath, a sign called the Auspitz sign. The plaques are typically symmetrical and appear on extensor surfaces: elbows, knees, lower back, and scalp. The borders are sharp. You can see exactly where the plaque ends and normal skin begins. In darker skin tones, psoriasis may appear more purple, gray, or darker brown rather than the classic red seen in lighter skin, and post-inflammatory hyperpigmentation is common after plaques resolve.

Eczema presents as dry, red, inflamed patches that are less well-defined. The skin may be rough, thickened from chronic scratching (a process called lichenification), or weeping and crusted during acute flares. Eczema favors flexural areas: the insides of elbows, behind the knees, neck, wrists, and ankles. In infants, it often starts on the cheeks and scalp. The borders are less distinct than psoriasis. Eczema can look different depending on the stage of the flare.

Understanding the visual differences between psoriasis vs eczema helps with accurate identification. Acute eczema may have small fluid-filled blisters (vesicles) that ooze when scratched. Chronic eczema becomes dry, scaly, and leathery. In darker skin, eczema may present with more prominent pigment changes, either hyperpigmentation or hypopigmentation, which can persist long after the inflammation resolves.

Hives (or urticaria) are sometimes confused with both conditions but are distinct. Hives appear as raised, red or skin-colored welts that come and go rapidly, often within hours. They're caused by mast cell degranulation and histamine release, not chronic inflammation or barrier dysfunction. When comparing hives vs eczema, hives are intensely itchy, migratory, and transient, while eczema and psoriasis are persistent.

Where Psoriasis and Eczema Show Up on the Body

Psoriasis has a predilection for areas of repeated trauma or friction, a phenomenon called the Koebner response. This is why plaques often appear on elbows, knees, and the scalp (areas subject to mechanical stress). Psoriasis can also affect the nails, causing pitting, thickening, and separation from the nail bed. Inverse psoriasis affects skin folds like the groin, armpits, and under the breasts, where plaques are smooth and shiny rather than scaly due to moisture in these areas. Scalp psoriasis extends beyond the hairline onto the forehead, a distinguishing feature from seborrheic dermatitis, which typically stays within the hairline.

Eczema distribution changes with age. In infants, it starts on the face (particularly the cheeks) and the scalp. As children grow, it migrates to the flexural areas: inner elbows, behind the knees, wrists, and ankles. Adults may develop hand eczema, particularly if they have occupations involving frequent handwashing or exposure to irritants. Eczema can also affect the eyelids, a common site for contact dermatitis. Unlike psoriasis, eczema rarely affects the nails, though chronic hand eczema can cause nail changes from inflammation of the surrounding skin.

What Triggers Flares in Psoriasis vs. Eczema

Psoriasis flare triggers

Psoriasis flares are driven by immune activation. Common triggers include:

• Infections, particularly streptococcal throat infections, can precipitate guttate psoriasis (a form characterized by small, drop-like lesions).
• Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, releasing cortisol and other stress hormones that dysregulate immune function.
• Certain medications (beta-blockers, lithium, antimalarials, and NSAIDs) can trigger or worsen psoriasis.
• Alcohol consumption is associated with more severe disease, possibly through effects on immune function and liver metabolism.
• Smoking is both a risk factor for developing psoriasis and a trigger for flares.
• Trauma to the skin (cuts, burns, or even tattoos) can induce new plaques at the site of injury.

Eczema flare triggers

Eczema flares are driven by barrier breakdown and allergen exposure. Key triggers include:

• Dry air, low humidity, and cold weather strip moisture from the skin, worsening barrier function.
• Hot showers, harsh soaps, and detergents remove natural lipids, further compromising the barrier.
• Environmental allergens (dust mites, pet dander, pollen) and dietary allergens (milk, eggs, nuts, soy, wheat) can trigger immune responses in sensitized individuals.
• Irritants like wool, synthetic fabrics, and fragrances cause direct inflammation.
• Stress worsens eczema through neuroimmune pathways, increasing mast cell activation and inflammatory cytokine release.
• Infections, particularly with Staphylococcus aureus (which colonizes eczematous skin at high rates), can trigger flares and complicate treatment.
• Hormonal fluctuations, particularly during menstruation and pregnancy, can affect eczema severity.

Why Two People With the Same Diagnosis Have Different Experiences

Genetics play a major role in both conditions but in different ways. Psoriasis has a strong genetic component, with multiple susceptibility loci identified, particularly in the HLA region. If one parent has psoriasis, a child has about a 10% chance of developing it. If both parents have it, the risk rises to 50%. However, not everyone with genetic susceptibility develops psoriasis, indicating that environmental triggers are necessary. Eczema is also highly heritable, with filaggrin gene mutations present in about 30% of people with moderate to severe atopic dermatitis. However, not everyone with filaggrin mutations develops eczema, and not everyone with eczema has filaggrin mutations, indicating that other barrier proteins and immune factors contribute.

Immune phenotype varies between individuals. Some people with psoriasis have predominantly Th17-driven inflammation, while others have more Th1 involvement. This affects treatment response. Biologics targeting IL-17 work well for Th17-dominant psoriasis but may be less effective in other subtypes. In eczema, some individuals have a Th2-dominant immune response with high IgE levels and multiple allergies, while others have a more Th1/Th17 pattern with less allergic sensitization. This affects whether allergen avoidance and antihistamines are helpful.

Skin microbiome composition differs between individuals and affects disease severity. In eczema, Staphylococcus aureus colonization is associated with more severe disease and frequent flares. Some individuals have more diverse skin microbiomes that may be protective. In psoriasis, the skin microbiome is less well-studied, but alterations in microbial diversity have been observed. Gut microbiome composition also influences systemic inflammation and may affect both conditions, though the specific mechanisms are still being elucidated.

Environmental exposures shape disease expression. People living in humid climates may have less severe eczema due to better skin hydration, while those in dry climates may struggle more. Occupational exposures matter. Healthcare workers, hairdressers, and cleaners have higher rates of hand eczema due to frequent handwashing and chemical exposure. Smoking and alcohol use worsen psoriasis but have less direct impact on eczema. Stress affects both conditions but through different pathways, with individual variation in stress resilience and coping mechanisms influencing flare frequency.

When Skin Symptoms Point to Something Systemic

Psoriasis is not just a skin disease. It's a systemic inflammatory condition. People with psoriasis have elevated levels of circulating inflammatory markers including C-reactive protein, IL-6, and TNF-alpha. This chronic inflammation increases the risk of cardiovascular disease, independent of traditional risk factors. Studies show that people with severe psoriasis have a 50% higher risk of myocardial infarction and stroke. The inflammation also contributes to metabolic syndrome, with higher rates of obesity, type 2 diabetes, and dyslipidemia. Up to 30% of people with psoriasis develop psoriatic arthritis, an inflammatory arthritis that can cause joint damage if untreated. Psoriasis is also associated with inflammatory bowel disease, particularly Crohn's disease, due to shared immune pathways.

Eczema is part of the atopic march, a progression of allergic diseases. Children with eczema are at higher risk of developing food allergies, asthma, and allergic rhinitis. The broken skin barrier in eczema allows allergen sensitization through the skin, a process called transcutaneous sensitization. This is why early and aggressive barrier repair in infancy may prevent the development of food allergies. Eczema is associated with sleep disruption due to nighttime itching, which can affect growth, development, and mental health in children. Adults with severe eczema have higher rates of anxiety and depression, partly due to the chronic itch-scratch cycle and the social impact of visible skin disease. Eczema is also associated with increased risk of skin infections, particularly with Staphylococcus aureus and herpes simplex virus (eczema herpeticum), which can be severe.

What Biomarkers Can Tell You When Topicals Aren't Enough

When psoriasis is severe, treatment-resistant, or associated with joint symptoms, systemic workup is warranted. High-sensitivity C-reactive protein and erythrocyte sedimentation rate reflect systemic inflammation. Lipid panels, fasting glucose, and HbA1c assess metabolic risk. Uric acid may be elevated and contributes to cardiovascular risk. If joint symptoms are present, rheumatoid factor and anti-CCP antibodies can help distinguish psoriatic arthritis from rheumatoid arthritis, though psoriatic arthritis is typically seronegative. Liver function tests are important before starting systemic therapies like methotrexate or biologics.

When eczema is severe, persistent, or associated with systemic symptoms, further investigation is indicated. Total IgE and specific IgE panels can identify allergic sensitization to foods or environmental allergens. Eosinophil count may be elevated in atopic individuals. Ferritin, vitamin D, and thyroid function tests can identify deficiencies or comorbidities that worsen skin health. If eczema is treatment-resistant, consider testing for contact allergens with patch testing, as allergic contact dermatitis can coexist with atopic dermatitis. If there are signs of infection, bacterial culture and sensitivity testing can guide antibiotic choice.

For both conditions, tracking inflammatory markers over time (not just reacting to individual flares) provides a clearer picture of disease activity and treatment response. Persistent elevation of inflammatory markers despite topical treatment suggests the need for systemic therapy. Reviewing eczema vs psoriasis pictures alongside biomarker data can help confirm diagnosis and guide treatment decisions.

Getting to the Root of What's Driving Your Skin

If your skin keeps flaring despite doing everything right with topicals, investigating systemic drivers through biomarker testing can reveal what is happening at the inflammatory, metabolic, and immune level, so your next step is based on data, not guesswork.